Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitriy Sonkin

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Elife|October 23, 2015
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumorsDmitriy Sonkin
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2022
Response to Mehta et alPeter Horak, Debyani Chakravarty, Dmitriy Sonkin
Lung Cancer Management|October 25, 2019
Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?Dmitriy Sonkin, Anish Thomas, Beverly A Teicher
BMC Systems Biology|February 12, 2016
Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activityAna B Pavel, Dmitriy Sonkin, Anupama Reddy
Cancer Genetics|June 23, 2024
Cancer treatments: Past, present, and futureDmitriy Sonkin, Anish Thomas, Beverly A Teicher
Human Mutation|August 2, 2017
Detection of homozygous deletions in tumor-suppressor genes ranging from dozen to hundreds nucleotides in cancer modelsLun-Ching Chang, Suleyman Vural, Dmitriy Sonkin
Human Mutation|February 18, 2021
MutSpliceDB: A database of splice sites variants with RNA-seq based evidence on effects on splicingAlida Palmisano, Suleyman Vural, Yingdong Zhao, et al.
Scientific Reports|August 27, 2021
TP53 isoform junction reads based analysis in malignant and normal contextsSuleyman Vural, Lun-Ching Chang, Laura M Yee, et al.
Molecular Oncology|May 4, 2013
Tumor suppressors status in cancer cell line EncyclopediaDmitriy Sonkin, Mehedi Hassan, Denis J Murphy, et al.
Plos Genetics|February 7, 2009
Genetic mechanisms in Apc-mediated mammary tumorigenesisMari Kuraguchi, Nana Yaw Ohene-Baah, Dmitriy Sonkin, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Elife|October 23, 2015
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumorsDmitriy Sonkin
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2022
Response to Mehta et alPeter Horak, Debyani Chakravarty, Dmitriy Sonkin
Lung Cancer Management|October 25, 2019
Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?Dmitriy Sonkin, Anish Thomas, Beverly A Teicher
BMC Systems Biology|February 12, 2016
Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activityAna B Pavel, Dmitriy Sonkin, Anupama Reddy
Cancer Genetics|June 23, 2024
Cancer treatments: Past, present, and futureDmitriy Sonkin, Anish Thomas, Beverly A Teicher
Human Mutation|August 2, 2017
Detection of homozygous deletions in tumor-suppressor genes ranging from dozen to hundreds nucleotides in cancer modelsLun-Ching Chang, Suleyman Vural, Dmitriy Sonkin
Human Mutation|February 18, 2021
MutSpliceDB: A database of splice sites variants with RNA-seq based evidence on effects on splicingAlida Palmisano, Suleyman Vural, Yingdong Zhao, et al.
Scientific Reports|August 27, 2021
TP53 isoform junction reads based analysis in malignant and normal contextsSuleyman Vural, Lun-Ching Chang, Laura M Yee, et al.
Molecular Oncology|May 4, 2013
Tumor suppressors status in cancer cell line EncyclopediaDmitriy Sonkin, Mehedi Hassan, Denis J Murphy, et al.
Plos Genetics|February 7, 2009
Genetic mechanisms in Apc-mediated mammary tumorigenesisMari Kuraguchi, Nana Yaw Ohene-Baah, Dmitriy Sonkin, et al.
Pageof 4